Robert Lee Page1, Vahram Ghushchyan2, Kavita Nair3. 1. Associate Professor of Clinical Pharmacy and Physical Medicine, School of Pharmacy and Medicine, and Clinical Specialist, Division of Cardiology. 2. Research Assistant Professor of Clinical Pharmacy, School of Pharmacy. 3. Associate Professor of Clinical Pharmacy, School of Pharmacy, University of Colorado University of Colorado Anschutz Medical Campus, Aurora, CO.
Abstract
BACKGROUND: Cardiovascular disease (CVD) continues to be a leading cost driver for payers in the United States.1 The American Heart Association estimates that more than 75 million individuals nationwide have some form of CVD. Individuals aged 20 to 45 years are developing CVD at higher rates than ever before. OBJECTIVES: To discuss the alarming increase in the rate of CVD in young adults (aged 18-45 years) previously only seen in older adults (aged ≥65 years) and describe the 5 primary risk factors (smoking, obesity, hypertension, diabetes, and dyslipidemia) that contribute to this new trend in the working-age population. DISCUSSION: Using Medical Expenditure Panel Survey data, this article outlines the increased prevalence of the 3 primary components of CVD-stroke, heart failure, and myocardial infarction-in younger adults and the cost impact on payers and on US society. The examples provided in this article highlight the need for increased efforts by all healthcare stakeholders, and by payers in particular, to develop prevention strategies for CVD risk factors targeted at young adults to curb the alarming rise in CVD among this age-group. CONCLUSION: This article provides compelling evidence for the need to institute prevention measures to curb the growing prevalence of CVD risk factors among younger adults in the United States.
BACKGROUND:Cardiovascular disease (CVD) continues to be a leading cost driver for payers in the United States.1 The American Heart Association estimates that more than 75 million individuals nationwide have some form of CVD. Individuals aged 20 to 45 years are developing CVD at higher rates than ever before. OBJECTIVES: To discuss the alarming increase in the rate of CVD in young adults (aged 18-45 years) previously only seen in older adults (aged ≥65 years) and describe the 5 primary risk factors (smoking, obesity, hypertension, diabetes, and dyslipidemia) that contribute to this new trend in the working-age population. DISCUSSION: Using Medical Expenditure Panel Survey data, this article outlines the increased prevalence of the 3 primary components of CVD-stroke, heart failure, and myocardial infarction-in younger adults and the cost impact on payers and on US society. The examples provided in this article highlight the need for increased efforts by all healthcare stakeholders, and by payers in particular, to develop prevention strategies for CVD risk factors targeted at young adults to curb the alarming rise in CVD among this age-group. CONCLUSION: This article provides compelling evidence for the need to institute prevention measures to curb the growing prevalence of CVD risk factors among younger adults in the United States.
Authors: Stephen S Johnston; Suellen Curkendall; Dinara Makenbaeva; Essy Mozaffari; Ron Goetzel; Wayne Burton; Ross Maclean Journal: J Occup Environ Med Date: 2011-01 Impact factor: 2.162
Authors: William S Weintraub; Stephen R Daniels; Lora E Burke; Barry A Franklin; David C Goff; Laura L Hayman; Donald Lloyd-Jones; Dilip K Pandey; Eduardo J Sanchez; Andrea Parsons Schram; Laurie P Whitsel Journal: Circulation Date: 2011-07-25 Impact factor: 29.690
Authors: David D McManus; Stephen M Piacentine; Darleen Lessard; Joel M Gore; Jorge Yarzebski; Frederick A Spencer; Robert J Goldberg Journal: Am J Cardiol Date: 2011-05-31 Impact factor: 2.778
Authors: Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go Journal: N Engl J Med Date: 2010-06-10 Impact factor: 91.245
Authors: Philippe Gabriel Steg; Robert J Goldberg; Joel M Gore; Keith A A Fox; Kim A Eagle; Marcus D Flather; Immad Sadiq; Rachel Kasper; Sophie K Rushton-Mellor; Frederick A Anderson Journal: Am J Cardiol Date: 2002-08-15 Impact factor: 2.778
Authors: Kirsten Bibbins-Domingo; Pamela Coxson; Mark J Pletcher; James Lightwood; Lee Goldman Journal: N Engl J Med Date: 2007-12-06 Impact factor: 91.245
Authors: Thomas Land; Nancy A Rigotti; Douglas E Levy; Mark Paskowsky; Donna Warner; Jo-Ann Kwass; Leann Wetherell; Lois Keithly Journal: PLoS Med Date: 2010-12-07 Impact factor: 11.069